First Business Financial Services’s AbbVie ABBV Stock Holding History

First Business Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	7,166 +326	+5%	+$72.3K	0.14%	66
2025 Q4	$1.56M	Sell	6,840 -438	-6%	-$99.8K	0.14%	63
2025 Q3	$1.69M	Sell	7,278 -150	-2%	-$30.5K	0.15%	62
2025 Q2	$1.38M	Buy	7,428 +19	+0.3%	+$3.53K	0.12%	69
2025 Q1	$1.55M	Hold	7,409	–	–	0.15%	68
2024 Q4	$1.32M	Buy	7,409 +415	+6%	+$76.3K	0.13%	71
2024 Q3	$1.38M	Sell	6,994 -371	-5%	-$69.2K	0.14%	64
2024 Q2	$1.26M	Sell	7,365 -1,193	-14%	-$198K	0.13%	67
2024 Q1	$1.56M	Buy	8,558 +1,199	+16%	+$207K	0.17%	56
2023 Q4	$1.14M	Sell	7,359 -6,358	-46%	-$927K	0.13%	65
2023 Q3	$2.04M	Buy	13,717 +89	+0.7%	+$13.1K	0.26%	33
2023 Q2	$1.84M	Sell	13,628 -140	-1%	-$20.5K	0.23%	40
2023 Q1	$2.19M	Sell	13,768 -35	-0.3%	-$5.35K	0.28%	25
2022 Q4	$2.23M	Buy	13,803 +1,715	+14%	+$263K	0.3%	22
2022 Q3	$1.62M	Buy	12,088 +87	+0.7%	+$12.5K	0.23%	34
2022 Q2	$1.84M	Buy	12,001 +452	+4%	+$69.1K	0.25%	32
2022 Q1	$1.87M	Sell	11,549 -171	-1%	-$24.8K	0.21%	37
2021 Q4	$1.59M	Buy	11,720 +2,450	+26%	+$289K	0.17%	40
2021 Q3	$1M	Buy	9,270 +6,858	+284%	+$784K	0.11%	69
2021 Q2	$272K	Hold	2,412	–	–	0.03%	137
2021 Q1	$261K	Buy	2,412 +206	+9%	+$22K	0.03%	126
2020 Q4	$236K	Sell	2,206 -219	-9%	-$21K	0.03%	121
2020 Q3	$212K	Hold	2,425	–	–	0.04%	117
2020 Q2	$238K	Buy	+2,425	New	+$214K	0.04%	112
2020 Q1	–	Sell	-2,585	Closed	-$229K	–	116
2019 Q4	$229K	Sell	2,585 -4,702	-65%	-$390K	0.04%	121
2019 Q3	$552K	Sell	7,287 -200	-3%	-$13.7K	0.09%	69
2019 Q2	$544K	Sell	7,487 -441	-6%	-$34.7K	0.09%	65
2019 Q1	$639K	Sell	7,928 -334	-4%	-$27.3K	0.11%	54
2018 Q4	$762K	Buy	8,262 +478	+6%	+$42K	0.13%	55
2018 Q3	$736K	Hold	7,784	–	–	0.12%	62
2018 Q2	$721K	Sell	7,784 -271	-3%	-$26.5K	0.13%	43
2018 Q1	$762K	Sell	8,055 -2,067	-20%	-$227K	0.14%	40
2017 Q4	$979K	Buy	10,122 +1,289	+15%	+$121K	0.18%	19
2017 Q3	$785K	Buy	8,833 +920	+12%	+$70K	0.16%	19
2017 Q2	$574K	Buy	+7,913	New	+$532K	0.12%	28

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Business Financial Services's ABBV Position: Q1 2026 in Review

First Business Financial Services increased its AbbVie (ABBV) stake by 4.8% in Q1 2026, buying an estimated $72.3K and bringing the position to 7,166 shares worth $1.56M. The position accounts for 0.14% of the portfolio, ranked #66.

First Business Financial Services first reported a position in ABBV in Q2 2017 and has held it in 35 quarters since. The position peaked at $2.23M in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

First Business Financial Services held 7,166 shares of AbbVie worth $1.56M as of Q1 2026.
First Business Financial Services bought 326 AbbVie shares in Q1 2026, an estimated $72.3K.
AbbVie made up 0.14% of First Business Financial Services's portfolio in Q1 2026, its #66 holding.
First Business Financial Services first reported a position in AbbVie in Q2 2017 and has held it in 35 quarters since.
First Business Financial Services's AbbVie position peaked at $2.23M in Q4 2022.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on First Business Financial Services's 13F filing for Q1 2026, filed 1 May 2026.